New

Turn ETF ideas into real portfolios. Try the builder now →

Advertisement
Advertisement
PJP
US Health Care
Passive
NYSE listed

Invesco Dynamic Pharmaceuticals ETF

This ETF provides exposure to Equally Weighted US Pharmaceuticals Equities

PJP performance and flow charts

Last update 9/15/2026 at 2:10 PM
Live
Closed
Last price
$123.43
-$1.53 (-1.22%) Today

Performance

-1.00.01.02.03.04.05.0%Aug 14Aug 21Aug 28Sep 4Sep 14

Flows

0 M10 M20 M30 M40 M
1 day price range
$123.43
$123.70
52 week price range
$90.16
$131.57
1W perf
-1.29%
YTD perf
+20.18%
YTD flows
+$166M
AuM
$547M
E/R
0.58%
TTM yield
0.85%
Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

Historic performance and flows

Data as of September 14, 2026
1M3MYTD1Y3Y5Y
Perf.-0.27%+10.81%+20.18%+38.79%+67.59%+66.54%
Flows+$36M+$158M+$166M+$180M+$114M-$33M
Data as of September 14, 2026
Advertisement

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Characteristics

The Invesco Dynamic Pharmaceuticals ETF is built to track the Dynamic Pharmaceutical Intellidex Total Return Index - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly). This share class generates a stream of income by distributing dividends.

Management strategyPassive
StrategyLong Only
ProviderInvesco
N° of holdings28
Replication methodDirect (Physical)
Asset classEquity
Dividend policyDistributing
Trailing 12m distribution yield
Join for free
Inception dateJune 23, 2005
ESGNo
TrackinsightTrackinsight

More data and info about PJP on Trackinsight

Exposure

Data as of July 31, 2026

Diversification

65.5%

Total weight of top 15 holdings out of 28

Top 15 Holdings

Abbott Laboratories
5.76%
AbbVie, Inc.
5.71%
Amgen, Inc.
5.33%
Johnson & Johnson
5.33%
Eli Lilly & Co.
5.25%
Merck & Co., Inc.
5.03%
Gilead Sciences, Inc.
4.58%
Pfizer Inc.
4.49%
Corcept Therapeutics, Inc.
4%
Amneal Pharmaceuticals, Inc.
3.88%
Liquidia Corp.
3.75%
Travere Therapeutics, Inc.
3.26%
Ligand Pharmaceuticals, Inc.
3.18%
Harmony Biosciences Holdings, Inc.
3.1%
Viatris, Inc.
2.85%

Sectors

Healthcare
100%
Other
-0%

Countries

USA
94.69%
Other
5.31%
Advertisement

Trading data

Last sale
9/15/2026 at 2:10 PM
$123.43
Previous close
$124.96
Consolidated volume
09/14/2026
Join for free
Average volume
30 days
Join for free
Average discount or premium
30 days
Join for free
Average Bid/Ask spread
30 days
Join for free

Volatility and drawdown

3M1Y3Y5Y
Volatility+18.23%+17.04%+16.36%+16.47%
Max drawdown
-5.67%-9.42%-16.11%-17.41%
Max drawdown duration
26d108d275d788d
Time to recover
N/A62d125d224d

Replication quality

Data as of August 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free
Tracking error
Join for free
Tracking difference
Join for free
1 year cumulative return difference
Best
Join for free
Worst
Join for free
daily return difference
Average
Join for free
Worst
Join for free
Frequently asked questions about PJP

What type of ETF is PJP?

PJP is a Passive ETF that provides exposure to Equity assets. It is managed by Invesco.

What index does PJP track?

PJP tracks the Dynamic Pharmaceutical Intellidex Total Return Index - USD, aiming to replicate its performance through full replication.

What does PJP invest in?

This ETF provides exposure to Equally Weighted US Pharmaceuticals Equities. It is part of the segment: US Health Care.

What is the expense ratio of PJP?

The total expense ratio (TER) of PJP is 0.58%, representing the annual fee charged by the fund manager.

When was PJP launched?

PJP was launched on June 23, 2005, marking its entry into the ETF market.

Who is the issuer of PJP?

PJP is issued by Invesco.

What is the AUM of PJP?

As of September 14, 2026, PJP manages $547.22 M, reflecting the total assets held in the fund.

How has PJP performed recently?

As of September 14, 2026, PJP delivered a return of -0.27% over the past month (1M performance), 10.81% over the past three months (3M), and 20.18% year-to-date (YTD).

What are the recent fund flows for PJP?

As of September 14, 2026, PJP has seen net flows of +$36M in the past month (1M flow) and +$166M year-to-date (YTD).

Does PJP pay dividends?

As of September 14, 2026, PJP has a trailing 12-month distribution yield of 0.85%.

How many holdings are in PJP

As of July 31, 2026, PJP holds 28 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.

How diversified is PJP?

As of July 31, 2026, PJP holds 28 securities, with 65.5% of its assets concentrated in its top 15 holdings.

What are the top holdings of PJP?

As of July 31, 2026, PJP holds a portfolio of 28 underlyings, with its largest positions including Abbott Laboratories, AbbVie, Inc. and Amgen, Inc.. These top holdings play a significant role in shaping the fund’s performance and exposure.

What countries or regions does PJP invest in?

As of July 31, 2026, PJP has its largest geographic exposures in USA.

What sectors or themes does PJP focus on?

As of July 31, 2026, PJP is primarily exposed to Healthcare.

The ETF Institute® is now affiliated with ETF Central

The CETF certification is the only FINRA listed professional designation focused on ETFs.

ETF Institute
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides
Advertisement

Recent educational content

Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs September 14, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 15, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs September 8, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 9, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs August 31, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 1, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs August 24, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · August 24, 2026

Browse all educational columns

Advertisement
ETF Comparison Tool

Have you tried our ETF Compare tool?

Compare ETFs like a pro. Analyze fees, performance, exposure & holdings side-by-side.